Biontech Se ADR
(BNTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 17,801,400 | 12,184,080 | 6,825,879 | 1,979,957 | -166,550 |
| Depreciation Amortization | 88,969 | 58,017 | 35,424 | 15,673 | 44,257 |
| Accounts receivable | -13,970,160 | -11,904,500 | -8,134,882 | -2,532,363 | -283,160 |
| Accounts payable and accrued liabilities | 1,793,698 | 1,360,679 | 989,223 | 308,031 | 233,695 |
| Other Working Capital | -12,695,140 | -10,932,130 | -7,436,402 | -2,324,156 | -106,345 |
| Other Operating Activity | 8,033,837 | 10,518,239 | 7,224,821 | 2,177,555 | 262,711 |
| Operating Cash Flow | $1,052,604 | $1,284,385 | $-495,937 | $-375,303 | $-15,391 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -443,899 | N/A | N/A | N/A | N/A |
| PPE Investments | -146,823 | -102,237 | -55,907 | -25,077 | -74,012 |
| Net Acquisitions | -24,609 | N/A | N/A | N/A | -69,273 |
| Purchase Of Investment | -23,071 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -31,352 | -14,740 | -14,097 | -9,042 | -22,176 |
| Other Investing Activity | -31,352 | -14,740 | -14,097 | -9,042 | -22,176 |
| Investing Cash Flow | $-669,753 | $-116,977 | $-70,005 | $-34,119 | $-165,460 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 178,230 |
| Debt Repayment | -62,231 | -2,241 | -1,687 | -844 | -1,789 |
| Common Stock Issued | 190,361 | 189,733 | 193,868 | N/A | 860,160 |
| Other Financing Activity | -16,682 | -18,749 | -13,374 | -4,581 | -14,557 |
| Financing Cash Flow | $111,448 | $168,744 | $178,807 | $-5,425 | $1,022,044 |
| Exchange Rate Effect | 76,547 | 58,253 | 30,364 | 30,622 | -51,795 |
| Beginning Cash Position | 1,431,788 | 1,427,068 | 1,458,170 | 1,459,017 | 593,024 |
| End Cash Position | 2,002,633 | 2,821,472 | 1,101,399 | 1,074,792 | 1,382,422 |
| Net Cash Flow | $570,846 | $1,394,404 | $-356,771 | $-384,225 | $789,398 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,052,604 | 1,284,385 | -495,937 | -375,303 | -15,391 |
| Capital Expenditure | -150,845 | -103,888 | -57,353 | -26,162 | -75,430 |
| Free Cash Flow | 901,759 | 1,180,498 | -553,290 | -401,465 | -90,821 |